OM

Opaleye Management Portfolio holdings

AUM $494M
1-Year Est. Return 68.17%
This Quarter Est. Return
1 Year Est. Return
+68.17%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$288M
AUM Growth
+$45.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
53
New
Increased
Reduced
Closed

Top Buys

1 +$7.5M
2 +$6.36M
3 +$6.24M
4
PHAT icon
Phathom Pharmaceuticals
PHAT
+$4.68M
5
KPTI icon
Karyopharm Therapeutics
KPTI
+$4.28M

Top Sells

1 +$6.74M
2 +$6.12M
3 +$5.25M
4
MRUS icon
Merus
MRUS
+$5.07M
5
KROS icon
Keros Therapeutics
KROS
+$4M

Sector Composition

1 Healthcare 98.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
26
$3.29M 1.14%
+826,200
27
$3.27M 1.14%
306,713
+235,413
28
$3.23M 1.12%
+252,046
29
$3.21M 1.12%
896,600
+775,585
30
$2.7M 0.94%
18,400
-17,612
31
$2.66M 0.93%
535,000
+314,350
32
$2.61M 0.91%
+272,200
33
$2.52M 0.88%
138,800
+137,300
34
$2.45M 0.85%
1,185,000
-371,800
35
$2.16M 0.75%
+261,800
36
$1.34M 0.47%
136,667
-63,266
37
$1.29M 0.45%
153,500
38
$983K 0.34%
+87,600
39
$936K 0.33%
+485,000
40
$490K 0.17%
245,000
-30,422
41
-417
42
-259,293
43
-10,000
44
-253,200
45
-28,750
46
-116,324
47
-6,065
48
-82,464
49
-365,000
50
-147,700